Exxon Mobil slides as crude prices retreat on renewed Iran ceasefire optimism

Exxon Mobil (XOM) is down 4.7% today. Here is some analysis on what might have caused this price movement.

Analysis: Exxon shares appear to be tracking a pullback in crude oil after markets reacted to fresh signs that the Iran conflict could de-escalate. When the perceived risk of prolonged supply disruption eases, the “war premium” in oil prices can unwind quickly, pressuring large integrated oil stocks.

Details:

Oil prices moved lower after comments that raised optimism about a potential ceasefire, reducing near-term fears around shipping disruptions and regional supply risks.

Brent crude fell back to around the $100-per-barrel level (down roughly 4%–5% on the day in early reports), a sizable single-session move that can translate into broad selling across the energy complex.

Broader global equities were stronger on the same risk-on backdrop, which can amplify sector rotation out of energy and into more economically sensitive areas when oil stress appears to be easing.

This decline may also reflect profit-taking after a volatile stretch in energy markets, as traders recalibrate expectations for realized prices and downstream margins if crude stabilizes lower.

Sources:

Associated Press, Axios

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$XOM Insider Trading Activity

$XOM insiders have traded $XOM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $XOM stock by insiders over the last 6 months:

DARRIN L TALLEY (VP - Corp Strategic Planning) has made 0 purchases and 7 sales selling 17,460 shares for an estimated $2,395,656.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$XOM Hedge Fund Activity

We have seen 2,076 institutional investors add shares of $XOM stock to their portfolio, and 1,724 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,130,356 shares (-70.4%) from their portfolio in Q4 2025, for an estimated $4,588,607,041
NORGES BANK added 6,185,309 shares (+10.8%) to their portfolio in Q4 2025, for an estimated $744,340,085
JPMORGAN CHASE & CO removed 4,661,338 shares (-6.2%) from their portfolio in Q4 2025, for an estimated $560,945,414
FMR LLC added 4,365,511 shares (+3.4%) to their portfolio in Q4 2025, for an estimated $525,345,593
PACER ADVISORS, INC. removed 4,344,733 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $522,845,169
BARCLAYS PLC removed 4,037,620 shares (-37.7%) from their portfolio in Q4 2025, for an estimated $485,887,190
LAZARD ASSET MANAGEMENT LLC removed 3,677,926 shares (-63.3%) from their portfolio in Q4 2025, for an estimated $442,601,614

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$XOM Congressional Stock Trading

Members of Congress have traded $XOM stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $XOM stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $100,000 on 02/10 and 1 sale worth up to $100,000 on 01/09.
REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/04, 02/02 and 0 sales.
SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/08.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$XOM Analyst Ratings

Wall Street analysts have issued reports on $XOM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 02/02/2026
Barclays issued a "Overweight" rating on 01/21/2026
Freedom Capital Markets issued a "Sell" rating on 01/06/2026
Jefferies issued a "Buy" rating on 12/10/2025
UBS issued a "Buy" rating on 12/01/2025
Piper Sandler issued a "Overweight" rating on 11/10/2025
Scotiabank issued a "Sector Outperform" rating on 11/03/2025

To track analyst ratings and price targets for $XOM, check out Quiver Quantitative's $XOM forecast page.

$XOM Price Targets

Multiple analysts have issued price targets for $XOM recently. We have seen 16 analysts offer price targets for $XOM in the last 6 months, with a median target of $150.5.

Here are some recent targets:

Devin McDermott from Morgan Stanley set a target price of $172.0 on 03/27/2026
Kim Fustier from HSBC set a target price of $158.0 on 03/20/2026
Nitin Kumar from Mizuho set a target price of $162.0 on 03/17/2026
Betty Jiang from Barclays set a target price of $163.0 on 03/16/2026
Ryan Todd from Piper Sandler set a target price of $186.0 on 03/12/2026
Jean Ann Salisbury from B of A Securities set a target price of $151.0 on 03/02/2026
Alastair Syme from Citigroup set a target price of $150.0 on 03/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.